Business

Warren Buffett's Berkshire Hathaway scores $60 million gain on Biogen after FDA approval sends the stock to record high | Theron Mohamed

Read more at markets.businessinsider.com

The famed investor’s company saw its Biogen stake soar in value after federal regulators approved the biotech’s Alzheimer’s drug.
Back to top button
error: